Screening for mild cognitive impairment among older Albanian patients by clinical pharmacists

Int J Pharm Pract. 2021 Mar 17;29(2):189-191. doi: 10.1093/ijpp/riab001.

Abstract

Objectives: To assess the prevalence of mild cognitive impairment (MCI) and its correlated factors among elderly Albanian patients using different screening tools applied by clinical pharmacists.

Methods: Patients aged 60 years old or more from two primary care centers located in two Albanian cities were included in the study. Two clinical pharmacists applied the MoCA/MoCA B (Montreal Cognitive Assessment/Basic) and the Mini-Cog in Albanian. A predictive multivariate logistic regression analysis and Kappa statistic were conducted.

Key findings: The prevalence of MCI using MoCA/MoCA B and Mini-Cog scales was 75.73 and 20.39%, respectively. There was a poor degree of agreement between them (Kappa 2.38). Older men had an increased risk of MCI.

Conclusions: The involvement of clinical pharmacists in screening for MCI might help in selecting vulnerable individuals for more specialized examination. The MoCA/MoCA B tool is recommended for higher sensitivity.

Keywords: clinical pharmacy; elderly; pharmaceutical care; primary care.

MeSH terms

  • Aged
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / epidemiology
  • Humans
  • Logistic Models
  • Male
  • Mass Screening
  • Middle Aged
  • Pharmacists*
  • Prevalence